Brief: Eiko Lifesciences Enters Into A Share Subscription Agreement With Reflux Pharmaceuticals Pvt Ltd
18/05/2023 10:29
May 18 (Reuters) - Eiko Lifesciences Ltd EIKO.BO :
* ENTERED INTO A SHARE SUBSCRIPTION AGREEMENT WITH REFLUX
PHARMACEUTICALS PVT LTD
* AGREEMENT FOR ACQUISITION OF UP TO 1.9 MILLION EQUITY
SHARES
BEING 25.01% EQUITY STAKE
* CONSIDERATION FOR 70 MILLION RUPEES
Source text for Eikon: ID:nBSE7d8p65
Further company coverage: EIKO.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eiko Lifesciences
See all newsBrief: Eiko Lifesciences To Buy 51% Stake In SSM Formulations
Brief: Eiko Lifesciences Ltd Says Buys 51% Of SSM Formulations
Brief: Eiko Lifesciences Says Proposal To Raise Funds Via Equity, Convertible Securities, Warrants
India's Eiko Lifesciences jumps on foray into logistics business
Brief: Eiko Lifesciences Announces Strategic Diversification Into Logistics And Container Management